Aptevo Therapeutics Inc. (APVO) financial statements (2020 and earlier)

Company profile

Business Address 2401 4TH AVE.
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12182137313845
Cash and cash equivalents1218213731287
Short-term investments     938
Restricted cash and investments     00
Receivables7876566
Inventory, net of allowances, customer advances and progress billings6774243
Inventory6774243
Prepaid expense4257755
Other current assets0134477
Total current assets:30374458496066
Noncurrent Assets
Operating lease, right-of-use asset44  
Property, plant and equipment4455566
Intangible assets, net (including goodwill)4555556
Intangible assets, net (excluding goodwill)4555556
Restricted cash and investments77777712
Other noncurrent assets431110 
Other undisclosed noncurrent assets  44   
Total noncurrent assets:23242223191924
TOTAL ASSETS:53616681677990
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4161416443
Accounts payable 121211   
Employee-related liabilities4335443
Debt2020    4
Other liabilities1111111
Other undisclosed current liabilities14111131110
Total current liabilities:38371718181518
Noncurrent Liabilities
Long-term debt and lease obligation342019191915
Long-term debt, excluding current maturities  2019191915
Operating lease, liability34  
Liabilities, other than long-term debt 000000
Other liabilities 000000
Other undisclosed noncurrent liabilities  44   
Total noncurrent liabilities:342323191916
Total liabilities:42414042373534
Stockholders' equity
Stockholders' equity attributable to parent12202639304456
Common stock0000000
Additional paid in capital180179179179158157157
Accumulated other comprehensive loss     (0)(0)
Accumulated deficit(168)(160)(153)(139)(127)(113)(101)
Total stockholders' equity:12202639304456
TOTAL LIABILITIES AND EQUITY:53616681677990

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues9977667
Cost of revenue
(Cost of Goods and Services Sold)
(6)(4)(6)(4)   
Gross profit:3513667
Operating expenses(11)(16)(14)(15)(15)(16)(17)
Other undisclosed operating loss    (4)(2)(3)
Operating loss:(8)(11)(13)(11)(14)(12)(12)
Nonoperating income (expense)2 (0)(1)(0)(0)(1)
Other nonoperating expense  (0)(1)(0)(0)(1)
Interest and debt expense(0)      
Loss from continuing operations before equity method investments, income taxes:(6)(11)(13)(12)(14)(13)(13)
Other undisclosed loss from continuing operations before income taxes(3)(1)     
Loss from continuing operations before income taxes:(8)(11)(13)(12)(14)(13)(13)
Income tax benefit 1     
Other undisclosed loss from continuing operations(1)      
Loss from continuing operations:(9)(10)(13)(12)(14)(13)(13)
Income from discontinued operations13   00
Other undisclosed loss before gain (loss) on sale of properties    (0)  
Net loss available to common stockholders, diluted:(8)(7)(13)(12)(14)(13)(13)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(8)(7)(13)(12)(14)(13)(13)
Comprehensive loss:(8)(7)(13)(12)(14)(13)(13)
Other undisclosed comprehensive income, net of tax, attributable to parent    000
Comprehensive loss, net of tax, attributable to parent:(8)(7)(13)(12)(14)(13)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: